Evidence map›Paper›PMID 32569355›Full record

Trial reportClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder.

Petra Jacobs, Daniel J Feaster, Yue Pan, Lauren K Gooden, Eric S Daar, Gregory M Lucas, Mamta K Jain, Eliza L Marsh, Wendy S Armstrong, Allan Rodriguez and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Coinfections and In-Hospital Mortality in a Group of Patients With HIV/AIDS: A Longitudinal Study.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Petra JacobsNational Institute on Drug Abuse, Bethesda, Maryland, USA.ORCID 0000-0003-1259-2480
Daniel J FeasterUniversity of Miami, Miami, Florida, USA.
Yue PanUniversity of Miami, Miami, Florida, USA.
Lauren K GoodenColumbia University, New York, New York, USA.
Eric S DaarLundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Gregory M LucasJohns Hopkins University, Baltimore, Maryland, USA.
Mamta K JainUT Southwestern Medical Center, Dallas, Texas, USA.
Eliza L MarshButler Hospital, Providence, Rhode Island, USA.
Wendy S ArmstrongEmory University School of Medicine, Atlanta, Georgia, USA.
Allan RodriguezUniversity of Miami, Miami, Florida, USA.
Carlos Del RioEmory University School of Medicine, Atlanta, Georgia, USA.
Lisa R MetschColumbia University, New York, New York, USA.

Funding

FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
Treatment outcomes and comorbidity in HIV-infected IDUK24DA035684 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M · 2014 to 2024
$1.5M
NIDA NIH HHS K24 DA035684NIDA NIH HHS T32 DA037801NIDA NIH HHS U10 DA013720NIDA NIH HHS UG1 DA013720
6 · The paper itself

Abstract

backgroundStudies have demonstrated benefits of antiretroviral therapy (ART) initiation on the day of human immunodeficiency virus (HIV) testing or at first clinical visit. The hospital setting is understudied for immediate ART initiation.

methodsCTN0049, a linkage-to-care randomized clinical trial, enrolled 801 persons living with HIV (PLWH) and substance use disorder (SUD) from 11 hospitals across the United States. This secondary analysis examined factors related to initiating (including reinitiating) ART in the hospital and its association with linkage to HIV care, frequency of outpatient care visits, retention, and viral suppression.

resultsOf 801 participants, 124 (15%) initiated ART in the hospital, with more than two-thirds of these participants (80/124) initiating ART for the first time. Time to first HIV care visit among those who initiated ART in the hospital and those who did not was 29 and 54 days, respectively (P = .0145). Hospital initiation of ART was associated with increased frequency of HIV outpatient care visits at 6 and 12 months. There was no association with ART initiation in the hospital and retention and viral suppression over a 12-month period. Participants recruited in Southern hospitals were less likely to initiate ART in the hospital (P < .001).

conclusionsPrevious research demonstrated benefits of immediate ART initiation, yet this approach is not widely implemented. Research findings suggest that starting ART in the hospital is beneficial for increasing linkage to HIV care and frequency of visits for PLWH and SUD. Implementation research should address barriers to early ART initiation in the hospital.

Indexed as

Anti-HIV AgentsHIV InfectionsSubstance-Related DisordersAmbulatory CareHIVHospitalsHumansAnti-HIV AgentsART initiationdisorderHIVhospitalsubstance usetreatment linkage

Identifiers

PMID32569355
PMCPMC8492224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.